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Whey proteins are mainly a group of small globular proteins. Their structures can 
be modified by physical, chemical and other means to improve their functionality. 
The objectives of this study were to investigate the effect of radiation on protein-
protein interaction, microstructure, and microbiological properties of whey 
protein-water solutions. Whey protein isolate (WPI) solutions (27-36% protein) 
were treated with different dosages (10-35 KGy) of gamma radiation. The protein 
solutions were analyzed for viscosity, turbidity, soluble nitrogen, total plate count, 
and yeast and mold counts. The interactions between whey proteins were also 
analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE), and scanning electron microscopy (SEM). The viscosity of protein 
solution (27%, w/w) was increased from 2.19 for the control to 4.78 mPa·s for the 
sample treated at 25 KGy, respectively, and viscosity also increased during storage 
at 23°C. The soluble nitrogen (10%, w/w) was decreased from 100% to 54.7% for 
control and the sample treated at 35 KGy. The effects of gamma radiation and 
storage time on viscosity of whey protein solutions were significant (p<0.05). 
Radiation treatment had significant impact on soluble nitrogen of whey protein 
solutions (p<0.05). SDS-PAGE results showed that intensity of the major protein 
band was reduced and it had smeared appearance for the treated samples and 
photographs of SEM also showed that protein-protein interactions induced by 
gamma radiation in the model system.  
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW 
 
1.1 INTRODUCTION 
Sealing wounds and stopping hemorrhages on the battleground have 
been going on for thousands of years. From then on, the suture was created and 
has become a common way to treat wounds in modern medical treatment. 
Currently, there are various types of absorbable and non-absorbable sutures of 
different sizes with different-size needles; and with more than forty different 
combinations are being used to close wounds and incisions (Quinn 2005). 
However, there are several manifest disadvantages to dealing with wounds by 
suture, such as high infection rate, physical pain, and long healing time. 
Therefore, alternative methods to suture have been evaluated including 
adhesive tapes, gums, and tissue adhesives.  
Given the shortcomings of some wound closure devices, interest in 
tissue adhesives has grown in the last half-century and especially in the last 
decades (Quinn 2005). Tissue adhesives have been used to close wounds and 
stop bleeding. Substantial advantages make tissue adhesives widely used in 
clinics. During some surgeries, tissue adhesives can be used as a way to seal 
the vascular system and some organs like the stomach. The use of proteins as 
a component in tissue adhesives has been previously studied and whey protein 
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has potential to be used as a functional polymer component for adhesives.  
Whey is the byproduct of cheese-making. Globally, dry whey and 
whey proteins (protein content 80% and below) exports totaled nearly 1.27 
million metric tons in 2010, up 12.5% versus 2009 exports (Horizons 2012). 
However, the total amount of whey is not being fully used every year. The 
main utilizations of whey are for animal feed, fertilizers, or as an ingredient 
for human foods. The United States is one of the world largest whey 
producers, which also produced fluid whey not fully used by human and 
animals. Disposal of whey by dumping into rivers was frequently used in the 
United States before environmental regulations were enforced (Cryan 2001, 
Onwulata 2008). Preventing pollution caused by disposal of whey and 
recovering its nutrient value have been two major factors of interest of using 
whey for decades. At the University of Vermont’s research lab, whey protein 
was used for formulation of wood and paper adhesives. It would be value-
added applications of whey protein for developing other products  
 
1.2 WHEY PROTEINS 
1.2.1 Whey Production 
Milk and milk products are used extensively because of their functional 
and nutritional properties. Milk provides diversified nutritional needs for 
human. The approximate composition of cow’s milk is shown in Table 1 
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(Potter 1995). Historically, milk proteins were extensively demanded for 
human health benefits. Caseins, representing about 80% of the total nitrogen 
(Fox 1989), and whey proteins are the two major proteins in bovine milk.  












  0.7 
12.9 
Whey is obtained from separating casein from bovine milk during 
cheese manufacture. Whey can be divided into two categories: sweet whey (a 
minimum pH of 5.6) and acid whey (a maximum pH of 5.1). Whey contains 
many types of proteins and essential amino acids for human. Yet without being 
fully utilized, currently whey is an ample and burdensome byproduct for the 
U.S. dairy industry. Whey is as an essential ingredient in the modern food 
industry due to its high concentration of protein, amino acids, and minerals, 
which are all high quality of nutrients for human consumption. Whey proteins 
are used in the manufacture of diet supplements, infant formuleverages, bakery 
products, and sports drinks.  
The utilization of whey and whey proteins has been in existence since 
antiquity. Portions of whey were used for humans and the rest was used for 
livestock forage and fertilizer. Even though the functional and nutritive values 
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of whey have been known for decades, whey as a byproduct is still not fully 
used. A substantial amount of whey is simply discarded every year. Whey has 
a biochemical oxygen demand (BOD) of 35,000-45,000 g/liter, and 100 liters 
of whey has a polluting strength equivalent to the sewage produced by 45 
people (Fox 1982). However, proteins and nutrients in whey are too valuable 
to be unutilized.  
Whey concentrating and drying are the two innovations to obtain the 
nutrients. The long-tube multiple-effect evaporator and the spray drier were 
the two important inventions in the early twentieth century in the whey 
industry and the spray drier is still used in modern dairy industry. Five types 
of membrane filtration (ultrafiltration, microfiltration, electrodialysis, 
nanofiltration, and reverse osmosis) were developed and applied to obtain a 
dry (<5% moisture content) product (Onwulata 2008). With the help of these 
processes, it is now possible and simple to obtain different concentrations of 
whey protein.  
1.2.2 Whey Protein Concentrate (WPC) and Whey Protein Isolate (WPI) 
WPCs and WPI are important whey products because of their high 
concentrations of proteins and wide usage. WPC can be obtained from 
ultrafiltration (UF) of whey. WPC may contain from 20 to 90% protein; WPC 
with 35% protein (WPC-35) is a common product (Onwulata 2008). WPI has 
a high concentration of protein (at least 90%) from whey. The lactose in WPI 
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is totally separated. WPC 80 production was 86,000 tons in 2011 and WPI 
production was expected to reach 27,600 metric tons in 2011 in the United 
States (Horizons 2012).  
The interest of using WPC and WPI is still growing for human health 
and benefits. Beneficial factors of WPC and WPI in food applications include 
its high protein and amino acid content; lack of pathogens, toxic compounds, 
and antinutritional factors; and abundant availability (Onwulata 2008). In the 
medicinal field and nutritional demands, products such as WPI supplements 
have also been developed from high concentrations of whey proteins using 
the processes of membrane filtrations.  
1.2.3 Whey Protein Chemistry 
The nutritive components of whey have interested scientists for 
centuries. Lactalbumin is the solid got from heating whey. Lactoglobulin 
which was a precipitate showed in research to form by the addition of 
magnesium sulfate or ammonium sulfate at low pH (Creamer 2003, Onwulata 
2008). Subsequently, bovine serum albumin, immunoglobulin, and other 
proteins were identified. Whey proteins are generally comprised of β-
lactoglobulin (β-LG) (50%), α-lactalbumin (α-LA) (20%) (Fox 1989), bovine 
serum albumin (BSA) (6%), immunoglobulins (Ig) (10%), and proteose-
peptones component glycomacropeptides (12%) (Onwulata 2008). Whey also 
contains lactoferrin (LF) and lactoperoxidase (LP), but the concentrations are 
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at very low levels. There are other minimal components in whey proteins that 
are remained from the cheese making process. Table 2 shows the compounds 
and functions of whey proteins in bovine milk (Wit 1998). 
Table 2. Compounds and Functions of Whey Proteins in Cow’s Milk 




































Even though WPC and WPI have higher protein concentrations, the 
amounts of various protein components such as β-LG and bovine serum 
albumin are not significantly changed.  
WPC and WPI contain more than half of β-LG, so the properties of β-
LG approximately reflect the properties of WPCs and WPIs. BSA and α-LA 
are the other two important proteins. β-LG and α-LA will be fractionated first 
and easily from whey proteins. Due to the binding ability and affinity for 
retinol of β-LG, it has the function of vitamin A transportation. The biological 
function of α-LA is to act as a specifier protein for lactose synthetase in the 
formation of lactose from galactose and glucose and α-LA is a calcium 
metallo-protein which Ca2+ may have a second messenger function for the 
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binding of α-LA to target proteins (Stuart 1986, Fox 1989). Bovine serum 
albumin (BSA), is a well-known transport protein for insoluble fatty acids in 
the blood circulatory system (Spector 1975, Fox 1989). Typical relative 
abundances, isoelectric points, molecular weights and denaturation 
temperatures of these proteins are listed in Table 3 (Wit 1981, Kinsella 1989). 
There are also many enzymes in whey and other minimal proteins.  
Table 3. Physical Characteristics of the Major Whey Proteins 


























aTd represent the temperature of denaturation. 
1.2.4 Structures of Whey Proteins 
Whey proteins are mainly groups of small globular proteins. The 
primary structure of protein is a peptide chain and amino acid residues (Figure 
1) (Walstra 1999). Several amino acids can interact to form a linear peptide 
chain. Proteins are long chains that most are comprised of more than 100 
amino acid groups. According to the primary structure, hydrogen bonds and 




Figure 1. Peptide Chain 
The secondary and tertiary structures show a high degree of 
organization with a great proportion of beta sheets (43-50% of the residues) 
and only 10-15% of a helix and 15-20% of beta turn (Damodaran 1997). 
Domains are used to describe the tertiary structure of protein molecules. The 
tertiary structures of β-LG and α-LA are shown in Figure 2 (Damodaran 1997). 
These molecules have their own distinguishing areas and functions. For 
example, domains have far-reaching impact on the denaturation. BSA has three 
specific domains for metal ion binding, lipid binding, nucleotide binding 
(Peters 1977, Fox 1989). The secondary and tertiary structures are important 
for protein functions so that the changes of these structures may cause the 







Figure 2. Tertiary Structures of β-LG (A) and α-LA (B). 
1.2.5 Functional Properties of Whey Protein 
Whey protein structures can be modified by physical, chemical and 
other means to improve their functionality. Factors including pH and ionic 
strength may have impact on the conformation of proteins.  
Denaturation of proteins means that the primary structure does not 
change but secondary and tertiary structures will be changed considerably. 
High pH, high temperature, some salts and other chemicals can be used for 
the denaturation of proteins. Occasionally, denaturation may be reversed to 
the original condition, but if aggregation occurs, it is an irreversible 
unfolding. Whey proteins can be aggregated and gelled when being thermal 
treated. The protein structures and properties may start to change at the 
temperature up to 60 °C and irreversible changes require higher temperatures 
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(above 70 °C). Color, viscosity, pH, solubility, and other physicochemical 
changes may occur caused by denaturation of whey proteins 
Protein-protein interactions occur at high temperature and these 
reactions can crosslink peptide chains and cause polymerization. These 
changes also include changes in primary structure. β-LG dissociates into 
monomers and the non-covalent bonds are first to be cleaved and the SH 
groups are activated to form disulfide bridges (Sienkiewicz 1990). At higher 
temperature, proteins polymerize into larger molecular weight.  
Gamma radiation can be used to sterilize WPI solutions without 
denaturing whey proteins by thermal treatment. However, there are some other 
side effects including gelation. Gelation occurs after gamma radiation and all 
the WPI solutions become more opaque. Except radiation, other factors like 
heat treatment, storage temperature, and total solids can also affect the degrees 
of gelation.  
Gelation begins with protein unfolding interactions. Ionic and 
hydrophobic interactions and/or covalent disulfide bonding are critical 
intermolecular interactions (to a varying extent) for gel formation (Fox 1989). 
As the gelation continues, aggregation occurs to form a gel. A schematic 
representation of the gelation mechanism is shown in Figure 3 (Onwulata 
2008). Gelation of whey proteins has its industrial values. For example, cheese 




Figure 3. A Schematic Representation of Gelation Mechanism 
Due to the functional and nutrient values of whey proteins, it is 
necessary and also possible to look into additional high value added 
applications of whey proteins. Moreover, WPI is cost inexpensive and readily 
available in the United States.  
In the functional foods laboratory of the University of Vermont, we 
developed many whey protein products, like wood adhesives, paper adhesives, 
and stick glues. If we could develop a protein-based tissue adhesive, it would 
be a more valuable application of whey protein isolate.  
 
1.3 TISSUE ADHESIVES 
1.3.1 Overview of Wound Closure 
People in ancient time had the knowledge to deal with trauma or 
incision caused by injuries. Ancient Chinese people used medicinal herbs 
wrapped in sackcloth to treat bleeding. It was fatal for those with deep wound 
when they could not get a necessary treatment. Then the suture was created to 
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treat wounds and hemorrhage by sewing. Suture technique has become the 
common and basic method for closing wounds nowadays. Absorbable sutures 
with different-size needles are not a common technique in modern medicine.  
Suture is the most popular method in clinic. Even when a few sutures 
are broken, other nearby sutures are not affected, resulting in an absent of total 
wound dehiscence. Suture are quick and easy to install and are generally non-
allergenic. However, the disadvantages of sutures should be noticed. High 
infection rate may be an urgent problem. They also require the use of anesthetic 
and are a slow method of wound closure that is costly and difficult to master 
for some practitioners (Quinn 2005). It may take a long time to heal by sewing. 
Sutures can cause scars that may be of concern when the surgical site is on the 
face or neck. Leakage of gas or fluid can lead to a serious failure. The use of 
needles can cause many problems like anxiety and contaminations.   
Therefore, alternatives to sutures are emerging for better wound care 
in clinics. Staples, clips, and surgical tapes are the common alternative 
techniques for wound closure including tissue adhesives. However, staples, 
clips and tapes all have their disadvantages. Therefore, using tissue adhesives 
to close and cure wounds has high possibility.  
1.3.2 History and Background of Tissue Adhesives 
The use of tissue adhesives for closing wounds may have more than a 
thousand years. Due to the improvement of techniques and the shortcomings 
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of common closure devices, investigation in tissue adhesives has gained 
significantly since the middle of twentieth century. The sequential World Wars 
stimulated the improvement of adhesives. Faced with large numbers of 
casualties suffering severe blood loss, surgeons in World War I began to use 
sheets of fibrin during surgery for the treatment of injuries (Sierra 1996). Many 
effective, quick, and convenient adhesive products appeared in numerous 
different types of surgery. In modern medicine, tissue adhesive has already 
become an alternative method to seal wounds that are important in clinical 
applications. Comparing to sutures and staples, the use of tissue adhesives 
provides a fast bonding and fully closure. 
1.3.3 Characteristics of Tissue Adhesives 
The use of tissue adhesives has shown numerous benefits in both 
clinical utilization and medical production. One of the advantages of tissue 
adhesives is the prevention of leaking of air or fluid. The surgical site of any 
vascular injury or a cavity organ surgery warrants an application for tissue 
adhesives. The use of tissue adhesives does not need to remove sutures later. 
There is also no risk of needle stick injury to the surgeon or assistant. Tissue 
adhesives also provide the possibility of surgery without development of 
scars after the healing process. The pinpricks of sutures make them a less 
attractive choice consideration in plastic surgery. Tissue adhesives also 
provide less time to heal comparing to sutures and significantly reduce the 
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pain of suture. Tissue adhesives act as topical wound sealants to provide an 
antimicrobial barrier to outside contamination, and to fixate structures where 
sutures and normal fixation devices such as plates and screws cannot be used 
(Quinn 2005). Most tissue adhesives are very convenient for clinical use and 
can be performed with the assistance of a nurse without professional surgical 
training. For example, some of them are applied in a matrix and can be 
activated by mixing in the surgical site just prior to use. Also the cost of 
tissue adhesives is not as expensive as sutures. With the enhancement of 
medical technology, there will be more effective adhesives for more 
extensive applications.  
1.3.4 Classifications of Adhesives 
Tissue adhesives in the United States can be categorized into five 
groups. There are several commercial products already available in the market 
for each category. Cyanoacrylate is the first one. They are not decomposed by 
our body. Cyanoacrylates can induce internal inflammation, tissue necrosis, 
and infection risks associated with foreign bodies (Reece 2001). Secondly, 
fibrin sealants are comprised of thrombin and fibrinogen. Fibrin sealants are 
biocompatible and biodegradable and they are not associated with 
inflammation, foreign body reactions, tissue necrosis, or extensive fibrosis 
(Ryou 2005, Spotnitz 2005). The composition of hydrogels is the third tissue 
adhesive that can be broken down, but they may require long time for reaction 
15 
 
under the conditions of light. Albumin-based compounds make the forth tissue 
adhesive that are glutaraldehyde glues which contain two compounds, albumin 
and crosslinker. BioGlue surgical adhesive is categorized in this group of tissue 
adhesive which is a two-component system. The last group is collagen-based 
adhesives. The composition is bovine collagen and bovine thrombin. This type 
of tissue adhesives is relatively expensive because it is comparatively new and 
more investigation may be needed for long-term effects.  
1.3.5 Protein Based Tissue Adhesives 
The benefits of using tissue adhesives has stimulated new approaches 
and developments. The use of proteins in adhesives is not novel. Egg white 
was used as a binding agent in ancient time (Quinn 2005). The use of proteins 
in adhesives is when a protein polymer reacted with a crosslinking agent, 
usually glutaraldehyde (GTA), to adhere to tissue surfaces. The most 
significant difference of this class of adhesives and sealants from the fibrin-
thrombin-based sealants is their independence of the coagulation cascade 
(Quinn 2005). Protein-based adhesives do not relate with coagulopathy or 
anticoagulation. The GR-Dial (Fehling, Germany), FocalSeal (Focal Inc., 
Massachusetts, USA), and BioGlue (CryoLife Inc., NW Kennesaw, GA, USA) 
are three examples for commercial tissue adhesives.  
Protein-based tissue adhesives can be absorbed by human and animal 
tissue during healing procedures. Proteins also have low toxicity but they are 
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not without disadvantages. Premature dissolutions of the tissue adherences 
frequently occurred due to enzymatic influence (Schwarz 1983). Proteins can 
cause allergy for some infants and some adults. GTA as a crosslinker may need 
more toxicological tests to be approved by Food and Drug Administration 
(FDA). Avoiding these disadvantages and difficulties would be a significant 
step forward for tissue adhesives. Proteins react with GTA to neutralize the 
toxicological effects of GTA on human body to make GTA an appropriate 
crosslinker.  
1.3.6 Principles of Protein Based Adhesives 
In this study, whey protein was used as protein polymer and GTA as a 
crosslinker. The linear structure of oily transparent GTA is a 5-carbon 
dialdehydes. GTA is a generally dependable material that invariably gives 
high yields of immobilized protein on the support (Walt 1994). GTA was 
used as a crosslinker in a tissue adhesive for hemostasis and urine leakage 
and also for decreasing blood loss during kidney surgery.  
The cross-linking of a protein-based tissue adhesive to itself and to 
the tissue is the result of the reaction between the amine groups of tissue 
proteins and the terminal aldehyde groups which are provide by the bi-
functional reagent GTA (Quinn 2005). The amines for this reaction are 
provided by the ε-amino groups of the side chains of lysine residues with ε-
NH2 in albumin and extracellular matrix proteins from the tissues (Hewitt 
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2001). Asparaginyl, glutaminyl, and arginyl residues also provide amino 
groups crosslinked with GTA. The mechanism of reaction of GTA with BSA 
and cell surface proteins to form dimers and polymers which is shown in 
Figure 4 (Quinn 2005). Proteins are stable enough after reacting with GTA 
which also has the function of immobilization. Proteins can form a soft and 
ductile barrier moving with human body.  
β-LG, α-LA, and BSA, respectively, contain 162, 123, and 583 total 
amino acid residues. The numbers of ε-amino groups are 37, 27 and 113, 
respectively, in these three proteins (Brew 1967, Hirayama 1990, Fox 2003). 
There are enough functional ε-amino groups for bonding tissue together. 







Figure 4. Mechanism of Reaction of GTA with BSA and Cell 
Surface Proteins 
1.3.7 Crosslinking Agents  
The choice of protein crosslinking agents usually affects the efficiency, 
toxicity, and bonding strength of tissue adhesives. There are usually three 
options used as protein crosslinking agents. GTA is the first one used as a 
cross-linking agent in tissue adhesives. BioGlue uses GTA as a crosslinker. 
The advantage of this approach is in the preservation of functioning renal 
tissue without compromising the oncologic outcome (Hidas 2006). GTA tissue 
adhesive can be used for hemostasis and decreasing the blood loss during 
nephron-sparing surgeries. The reaction of GTA with proteins is immediate, 
reaching full bonding strength within 5 minutes. The use of this tissue adhesive 
significantly reduced the volume and the rate of postsurgical bleeding, and 
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occasionally the inflammatory response. Although GTA is wildely used in 
many tissue adhesives, the toxicity of GTA should be noticed. GTA can cause 
cytotoxic effects. Superior bonding and sealing capabilities to tissues as well 
as to synthetic graft materials allowing air-tight and blood-tight repair 
properties are claimed for BioGlue (Furst 2005). 
Genipin is another type of crosslinking agents. Genipin can react with 
chitosan and some peptides that contain primary amine groups. Genipin has 
the advantages of high bonding strength and low toxicity. It has recently 
provoked interest for its ability to crosslink chitosan and certain proteins 
containing residues with primary amine groups, particularly, gelatin and soya 
protein isolates (Butler 2003). Genipin can be widely used to crosslink gelatin 
in the study of tissue sutures, soy protein isolates in food applications, and so 
forth. The reason why genipin was used in these applications is that the 
cytotoxicity is much lower than other cross-linking agents such as 
glutaraldehyde. However, the bonding strength of genipin is not as sufficient 
as compared to glutaraldehyde. The reaction time for reaching full bonding 
strength between gelatin and genipin can be as long as 24 hours (Yao 2003).  
Tartaric Acid Derivative (TAD) is relatively novel cross-linking agent 
that is widely used in many fields. TAD was prepared by reacting carboxyl 
groups of tartaric acid with N-hydroxysuccinimide in the presence of 
carbodiimide (Iwasashi 2009). It can reach full bonding strength within 5 
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minutes and the strength can be several times that of fibrin glue. TAD is an 
organic acid that can shorten bonding time and also has adequate bonding 
strength. TAD can be slowly dissolved and reacts with human serum albumin 
solution. Tartaric acid can be derived from fruit extracts and TAD tissue 
adhesives are less toxic. It has a limitation that rodent regeneration is better 
than in human beings, and the period for gel absorption and wound healing 
may differ in actual human use (Iwasashi 2009). 
1.3.8 Testing of Tissue Adhesives 
The physical bonding strength test is the primary test for evaluation 
criteria of any tissue adhesive development. Lap-shear bonding strength is 
tested for tissue adhesives according to the method of ASTM F2255-05. The 
fresh porcine skin graft is cut into the size shown in Figure 5. The bonding 
strength is tested by an Instron machine (Instron Corporation, Canton, MA, 






Figure 5. Depiction of Lap-shear Bonding Strength Test Specimen 










BioGlue®, a commercial tissue adhesive, is approved for clinical tissue 
bonding and vascular sealing by the US Food and Drug Administration (FDA) 
as a medical device. It has also been approved by the European Union and 
elsewhere for extensive clinical use. The major components of BioGluee are 
BSA (45%, w/v) as protein polymer and GTA (10% w/v) solution as 
crosslinker (Quinn 2005). BioGlue is provided in a double-tube syringe that is 
stored at temperature (23°C). The ratio of BSA and glutaraldehyde is four to 
one. The syringe is inserted through an applicator which is shown in Figure 6. 
During a surgery, the cover on the top of the syringe is removed and a sterilized 
mixer is attached to the syringe ready for use. The compounds are mixed in the 
mixer when the applicator is applied by pushing forth and back. The pre-filled 
syringe is available in 2, 5, and 10 mL volumes for different requirements in 
surgery (Quinn 2005).  
 
Figure 6. Delivery System of Tissue adhesive 






BioGlue mainly contains albumin which can be degraded by 
proteolysis. The resorption of BioGlue is slow. BioGlue was approved for 
biocompatibility tests which contain toxicity, cytotoxicity, and mutagenicity 
studies. The cost of BioGlue is from $50 to $135/ml depending on different 
size (Quinn 2005).  
If BSA is a suitable protein polymer for tissue adhesive, whey protein 
that contains a group of globular proteins including BSA and a large number 
of free amino groups, should be suitable for a tissue adhesive polymer as well. 
WPI as a protein polymer may reach full bonding strength comparable as 
BioGlue. Moreover, WPI is cheaper and more abundant than BSA. Also, the 
model system can be sterilized by gamma radiation easily and effectively and 
maintain aseptic. 
 
1.4 GAMMA RADIATION 
1.4.1 Overview of Gamma Radiation 
The two types of radiation are electromagnetic and corpuscular. 
Electromagnetic radiation consists of self-propagating electric and magnetic 
disturbances (Urbain 1986). Corpuscular radiation contains massive particles 
with energy. Gamma rays are electromagnetic radiation of nuclear origin with 
short wavelengths in the region of 3 × 10-9 cm to 3 × 10-11 cm (Spinks 1976). 
Gamma rays are high frequency and energy photons. Gamma radiation is 
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ionizing so it is biologically hazardous. Gamma radiation is produced from 
gamma decay and the energy is emitted from high energy stage to low energy 
stage. When gamma radiation passes through matter, it is absorbed by 
processes which set electrons in motion and these electrons produce ionization 
of other atoms or molecules in the medium (Dendy 2012).  
The absorbed energy from the radiation is the matter rather than 
wavelength. The energy can be described by wavelength shown in the equation 
where h is Planck’s constant, c is the velocity of light, and λ is the wavelength 
(Spinks 1976). Cobalt-60 is a common source of radioactive isotope of gamma 
radiation. 
E=hc/λ 
Gamma radiation is described by one of the units called gray (Gy). 
Gamma radiation can cause damage at a cellular level such as skin burns. It 
also causes damage like DNA damage, cell death, and increasing incidence of 
cancer. Due to the protection of personnel safety away from hazard effects of 
gamma radiation, it must be surrounded by enough thick walls made from high 
density materials and is usually put underground. The properties of gamma 
radiation can be exploited in many applications. For example, gamma radiation 
can be used to kill microorganisms, to treat some types of cancer, and to form 
diagnostic images. 
1.4.2 Application of Gamma Radiation  
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Food irradiation is another application of gamma radiation that 
employs an energy form to treat foods for sterilization. Some ionizing radiation 
is capable to pass through some foods. Through physical effects they interact 
with the atoms and molecules that make up the food and also those of food 
contaminants, causing chemical and biological consequences which can be 
utilized in beneficial ways (Urbain 1986). Food irradiation benefits include 
disinfection, inhibiting sprouting, and pathogen killing. Food irradiation also 
prolongs the shelf life of foods and delays ripening.  
Furthermore, gamma-irradiation generates sterile biomaterials which 
could be used in pharmaceutical or biomedical applications (Ressouany 
1998). In this study, gamma radiation was used to sterilize WPI solution as a 
part of tissue adhesive. The ideal tissue adhesive would have at a minimum 
the following capabilities which are safe and biodegradable, effective, easily 
usable, affordable, and approvable by government regulatory agencies for use 
in the United States (Sierra 1996). The sterilization of WPI solution is, 
therefore, very important for the safety of protein-based tissue adhesives. 
Thermal treatments, filtration, and irradiation are three commonly used 
methods for sterilizing food products, but heating can cause protein 
denaturation. Furthermore, WPI solutions in the desired range of 
concentrations (27%-36%) are too viscous to be filter sterilized. Gamma 
radiation may offer the only practical alternative method to sterilize WPI 
25 
 
solutions. Gamma radiation may offer an alternative and practical method to 
sterilize WPI solutions. However, gamma radiation can cause chemical and 
physical changes that could functional affect properties of WPI solutions. 
Chemical changes in the proteins caused by gamma-irradiation include 
degradation, cross-linking, aggregation and oxidation by oxygen radicals that 
are generated in the radiolysis of water (Lee 2005). 
1.4.3 Interaction of Matter with Gamma Radiation 
Gamma radiation interacts with orbital electrons of matter at the atomic 
scale. The energy absorbed is related to the density, the atomic cross-section, 
and thickness of the material. There are three situations including photoelectric 





Figure 7. Interaction of Gamma Rays. (a) Photoelectric Effect. (b) 
Compton Scatter. (c) Pair Production 
When an individual gamma photon interacts with a massive object, 
such as shielding, the primary interaction takes place with one electron or the 
nuclear field of a single atom (Faires 1981). An electron is ejected and passes 
into the mass of the object where its energy is dissipated. In the photoelectric 
effect, a gamma photon strikes an electron and the energy is transferred to the 
electron and the photon is totally stopped. In Compton, scatter the photon 
interacts with an atomic electron and enough energy is transferred to the 
electron for the ejection from the atom (Faires 1981). The photon maintains 
some energy to become a new photon with a different direction and lower 
energy. The pair production situation happens at the absorption of a high 
27 
 
energy gamma photon. The photon collides with the electric field of a nucleus 
to generate a positron pair (Faires 1981). The ejected position will bump into 
an electron and the annihilating process will generate two gamma photons.   
 
1.5 OBJECTIVES 
The objectives of this study were to develop a method to sterilize whey 
protein solution using gamma radiation and to formulate a tissue adhesive 

















CHAPTER 2: MATERIALS AND METHODS 
 
2.1 MATERIALS 
WPI with a protein content of 90% was purchased from FonterraTM 
(Auckland, New Zealand). Glutaraldehyde (GTA) (50%) was purchased from 
Fisher Scientific Inc. (Pittsburgh, PA). Aerobe count and yeast and molds 
count Petrifilms were purchased from the 3M™ Petrifilm™. Porcine skins 
were purchased from a local supermarket. Pre-filled buffer (99 ml) was 
purchased from Fisher Scientific Inc. (Pittsburgh, PA).  
 
2.2 METHODS 
2.2.1 Model System Preparation 
Protein tissue adhesive was comprised of WPI solution and GTA 
solution. WPI powder was dissolved in deionized water at concentrations of 
27%, 30%, 33%, and 36% (w/w). The solutions were mixed with a blender for 
15 minutes at 1000 RPM. WPI solutions were stored in a refrigerator at 4°C 
overnight. Defoamed WPI solutions were poured into 10 ml centrifuge tubes 
and labeled for protein concentrations and irradiated dosages. Various 
concentrations of WPI solutions were treated by different dosages (10 – 25 
KGy) of gamma radiation. Treatment of gamma radiation at different levels on 
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protein solutions were shown in Table 4. The treated WPI solutions were stored 
at room temperature. GTA (50%) was diluted with sterilized deionized water 
to 6.0%, 8.0%, 10.0% and 12.0% (v/v).  





27% 30% 33% 36% 
10 KGy S1-1 S1-2 S1-3 S1-4 
12.5 KGy S2-1 S2-2 S2-3 S2-4 
15 KGy S3-1 S3-2 S3-3 S3-4 
17.5 KGy S4-1 S4-2 S4-3 S4-4 
20 KGy S5-1 S5-2 S5-3 S5-4 
25 KGy S6-1 S6-2 S6-3 S6-4 
2.2.2 Microbial analysis 
Each sample (1 ml), respectively, was diluted to 10-1 with 9 ml sterile 
buffer and another 1 ml of the sample was diluted to 10-2 with 99 ml sterile 
buffer. 10-3 dilution was prepared by adding 1 ml 10-1 dilution to 99 ml of 
sterile buffer. Each different dilution was applied on aerobe count and yeast 
and molds count Petrifilms according to the manufacturer’s instructions. 
Triplicates for each sample were tested for aerobe, yeast and molds. The top 
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of films was lifted to expose the surface and 1 ml of each dilution (10-1, 10-2, 
and 10-3) from each sample was added inside a circular foam barrier on Aerobe 
count Petrifilms and yeast and molds count Petrifilms. The petrifilm has a 
circular bottom with a barrier and a top to enclose the sample within the 
Petrifilm. Petrifilms were gradually rolled down and distributed evenly by a 
plastic spreader and gas bubbles were excluded by this process. WPI solutions 
prior to gamma radiation treatment were also tested by aerobe count and yeast 
and molds Petrifilms. After a few minutes of drying, aerobe count Petrifilms 
were put into incubator at 37°C for 48 hours and yeast and molds count 
Petrifilms were put at room temperature for at least 48 hours. The readable 
plate count for Petrifilm is between 25 to 250 colonies forming units or CFUs. 
There will be splotches or spots surrounded by bubbles for molds if there are 
CFUs present. 
2.2.3 Viscosity 
Apparent viscosity of various concentrations of WPI solutions before 
and after irradiation at various dosages was determined at room temperature 
(23°C) using a Viscometer (Model DV-I Prime, Brookfield Engineering Labs 
Inc., Stoughton, MA, USA). Samples were tested with spindle # 3 at 100 
RMP. The viscosity reading on the screen was recorded after the spindle has 




2.2.4 Gelation during Storage 
Gelation was observed every other week during the storage. If the 
WPI solutions showed solidifying properties then they are not suitable for 
use of tissue adhesives.  
2.2.5 Soluble Nitrogen  
The pH 4.6-soluble nitrogen of WPI solutions was tested by the method 
of International Dairy Federation (IDF 1964a). Four ml samples of each 
combination were weighed, respectively, and added into 10 ml centrifuge tubes. 
Four ml of distilled water was transferred into each tube. Acetic acid (10%, 
v/v, 0.4 ml) was added into every tube, mixed and kept for 10 minutes. Na 
acetate (1M, 0.4 ml) was added into every tube and mixed gently. All tubes 
were volumed up to 10 ml with deionized water. Total sample of mixture was 
filtrated through Fisher Q 8 filter paper. The precipitate was removed and a 
sample (2 ml) of filtrate was taken for nitrogen determination by the Kjeldahl 
method.  
2.2.6 Lap-shear Bonding strength  
Lap-shear bonding strength was measured with the method of ASTM 
standard (ASTM 2005). Fresh porcine skin was cut into 5.08 cm × 2.54 cm 
pieces with a No. 15 UnibladeTM surgical scalpel (AD Surgical, Sunnyvale, 
CA, USA). Two skin strips were adhered on two aluminum blocks with dermal 
side up with Gorilla® super glue (The Gorilla Glue Company, Cincinnati, OH, 
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USA). The test specimens were kept moist by wrapping with gauzes soaked 
with phosphate buffered saline (PBS) (Fisher Scientific, Fair Lawn, NJ, USA) 
and placed in an environmental chamber at 25 °C. 80 µl of WPI solution and 
20 µl of GTA solution were applied on the skin dermal side and mixed with a 
small steel spatula and then the two porcine skin strips were lapped together 
by the fixture as showed in Figure 5. The bonding area was 2.54 cm × 1.0 cm. 
Glued specimens were kept for 30 min and tested by an instron 5566 machine 
(Instron Corporation, Norwood, MA, USA). Specimens were put tightly in the 
loading cell of the Instron and the test was started until the two porcine skin 
stripes separated. The maximum load (N) was recorded and the bonding 
strength (kPa) was calculated. The bonding strength (36% protein, 10% GTA) 
was also compared with a commercial tissue adhesive.  
2.2.7 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE was conducted with separating and stacking gels 
according to the method of Guo et al. (Guo 1995). The glass plate 
sandwiches were assembled and sealed with Vaseline. Total volume of 80 ml 
sample buffer, separating gel, and stacking gel were prepared. 50μl sample 
were added into 10 ml sample buffer and mixed well. Equal amounts of 
samples were loaded on each lane for comparison. SDS-PAGE was 
performed at a constant current of 150 V for 10 minutes at 60 mA and then at 
200 V mA at 25 mA for an additional 30-40 minutes at room temperature. 
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Gels were fixed with 25% (v/v) propan-2-ol and 10% glacial acetic acid 
overnight. Gels were stained with stained buffer and stored at room 
temperature for 5 hours. Then the gels were disdained with distained buffer 
for 2-3 hours until the blue color was washed off to make the gels transparent 
and the bands clearly visible. 
2.2.8 Scanning Electron Microscopy (SEM) 
On two separate occasions, scanning electron microscopy (SEM) was 
for analyzing the microstructure of WPI solutions. For the first trial, whey 
protein adhesives were prepared by loading in an applicator to mix and 
spread the components. The material was extruded out onto a piece of 
parafilm and cured at room temperature. Then the material was frozen in 
liquid nitrogen and fractured. The pieces were mounted on aluminum stubs 
with silver conductive paste and carbon coated and then sputter coated with 
Au/Pd (approximately 4 nm) (Hendricks 1983). Treated samples before and 
after irradiation were then scanned on a FEI Quanta 200 FEG ESEM Mark II 
scanning electron microscope (UMASS, Worcester, MA, USA) at an 
accelerating electron voltage of 10 kV. Images were recorded at 25,000 X 
magnifications. Second trial, SEM images were obtained at the University of 
Vermont. Samples were dehydrated and obtained at 10,000X magnifications. 




2.2.9 Statistical Analysis 
SPSS® Version 21 software for Linux (SPSS Inc., Chicago, IL, USA) 
was used for statistical analysis. The data were analyzed by ANOVA which 
analyzes the effects of gamma radiation treatment and storage time. Significant 
differences between group means of the variations were observed in 



















CHAPTER 3: RESULTS AND DISCUSSION 
 
3.1. RESULTS AND DISSCUSSION 
3.1.1 Effect of Radiation on Microbial Properties  
The WPI solutions were tested for aerobic microorganisms and yeast 
and molds by 3M™ Aerobic Count Petrifilm™ and Yeast and Molds 
Petrifilm™, respectively, for six months after gamma radiation treatment (10-
25 KGy). No microorganism have been found during these six months for 
treated samples in both aerobic count Petrifilms and yeast and molds Petrifilms. 
The smallest dosage (10 KGy) of gamma radiation that was applied in this 
study sufficient to sterilize WPI solutions and to eliminate the presence of 
viable microorganisms. The tests for aerobic bacteria and yeast and molds 
before the treatment of gamma radiation were also conducted in Chinese 
Academy of Agricultural Sciences, Beijing, China. The colonies on aerobic 
count Petrifilms were 107, 43, and 93 for 10-1 dilution so the mean result was 
810 CFU/ml and the yeast and molds Petrifilms showed that the mean result 
was 200 CFU/ml.  
WPI was dissolved with deionized water and stored at room 
temperature (23°C). The conditions, which include water activity, temperature, 
oxygen, food, and acidity, are suitable for aerobic mesophilic bacteria to 
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generate and grow. Aerobic count Petrifilms were incubated for 48 hours at 
35°C and Yeast and Molds Petrifilms were incubated for 48-96 hours at room 
temperature that created optimum conditions. Similar as incubation conditions, 
microorganisms have not grown or generated during six-month storage. Spores, 
which are formed in unfavorable conditions and are able to develop into new 
organisms under favorable conditions, did not grow and generate in the 
systems. 
3.1.2 Viscosity 
Viscosity is a measurement of pressure which comes from interactions 
or collisions of particles moving in different directions and velocities in fluid. 
Technically, with regard to homogeneous solution the higher concentration of 
the solution, the higher viscosity the fluid shows. Temperature significantly 
impacts viscosity. In this study, the temperature was kept constant at room 
temperature to eliminate interference.  
The viscosity was used to measure the effects of gamma radiation on 
polymerization of WPI solutions. The viscosity of WPI solutions was 
influenced by the treatment of various dosages of gamma radiation. The 
viscosity before and after gamma radiation treatment was shown in Figure 8. 
The viscosity of protein solution (27%, w/w) was increased from 2.19 for the 
control to 4.78 mPa·s for the sample treated at 25 KGy, respectively. For 
30% protein solution, the viscosity was increased from 4.87 for the control to 
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12.72 mPa·s for the sample treated at 25 KGy. The viscosity of protein 
solution (33%) was 11.2 for the control and then decreased to 10.14 and 
11.15 mPa·s at 10 KGy and 12.5 KGy but increased over 15 KGy. For 
protein solution (36%), the viscosity was from 10 KGy to 15 KGy and then 
increased to 71.6 mPa·s at 25 KGy. Gamma radiation has the effects of 
fragmentation and aggregation. Proteins can be converted to higher 
molecular weight aggregates, due to inter-protein cross-linking reactions, 
hydrophobic and electrostatic interactions, as well as the formation of 
disulfide bonds (Davies 1987, Lee 2005). However, at low dosage, gamma 
radiation exhibits the effect of fragmentation. Figures 9 to 12 also show the 
viscosity was increased during storage for six months after gamma radiation.  
3.1.3 Gelation 
WPI solutions were treated by the highest dosage of gamma radiation. 
As long as WPI solutions begin to gel, they are not used for tissue adhesives 
any more. Protein solutions (27%) treated by 25 KGy gelled within six-
month storage. Protein solutions (30 and 33%) treated by 15, 17.5, 20, 25 
KGy all gelled. Protein solutions at 36% treated by 15, 17.5, 20, 25 KGy 
gelled in first 3 months. The one treated by 12.5 KGy got gelled in fifth 
month.   
3.1.4 Soluble Nitrogen 
Gamma radiation affects functional and structural properties of 
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proteins including nitrogen solubility. Soluble nitrogen also measures the 
effects of gamma radiation on polymerization of WPI solutions. The nitrogen 
solubility was decreased by gamma radiation due to protein-based 
conformational modification, shown in Figure 13. The soluble nitrogen (10%, 
w/w) was decreased from 100% to 54.7% for the untreated sample and the 
sample treated at 35 KGy. The statistical analysis of soluble protein indicated 
that radiation treatment had significant impact on soluble nitrogen of whey 
protein solutions (p<0.05).  
3.1.5 Lap-shear Bonding Strength  
Protein/ glutaraldehyde tissue adhesive was tested for bonding strength 
at the first week after gamma radiation treatment. On two different occasions, 
bonding strength was tested every other two month. Glutaraldehyde (8% and 
10%) which was used as a crosslinking agent in this study reacted with various 
concentrations of WPI solutions before and after gamma radiation treatment. 
The results for bonding strength are shown in Figures 14, 15, and 16.  
For the same whey protein solution, bonding strength was generally 
increased with increasing dosage of gamma radiation and also with increasing 
concentration of GTA. However, bonding strength is influenced by many other 
factors during the operation. For instance, after mixing WPI solution and 
glutaraldehyde, the tissue adhesive may flow away from the bonding area 
before solidification which may decrease the bonding strength.  
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Generally, providing the same percentage of glutaraldehyde, higher 
dosage of gamma radiation leads to higher bonding strength. Higher 
concentration of protein also increases the bonding strength. Increasing the 
percentage of protein also provides a method to enhance bonding strength 
when the concentration of glutaraldehyde and the dosage of gamma radiation 
remain constant.  
During storage, bonding strength showed increasing. The 33% protein 
with 10% and 12% glutaraldehyde with 12.5 KGy gamma radiation bonding 
strength were 20.69 and 23.61 N, respectively. The results of bonding strength 
(36% protein) and commercial tissue adhesive are shown in Figure 17. The 
fifth month bonding strength was comparable to the commercial tissue 
adhesive. Overall, bonding strength increases during storage at room 
temperature. We conclude that, WPI solutions start to gel during storage. If 
gelation has already begun before gamma irradiation, proteins may be 
polymerized and denatured which can cause a lack functional and structural 
properties.  
3.1.6 Protein Profile 
Polymerization caused by gamma radiation was also used SDS-PAGE 
to determine. On the base of electrophoretic mobility, proteins are conformed 
to several lines on the gel depending on their molecular weight. Sodium 
dodecyl sulfate (SDS) is used to form linear-structural proteins and cause a 
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negative charge so that proteins migrate from negative electrode to positive 
electrode.  
Protein profiles of WPI solution were shown in Figure 18. The SDS-
PAGE profiles (10% and 30%) both show that proteins were cross-linked in 
the samples treated by gamma radiation under the same amount of samples. 
The protein profiles show non-quantitatively that proteins were aggregated to 
higher molecular weights than samples untreated by gamma radiation. Any 
amino acid radical that is formed within a peptide chain could cross-link with 
an amino acid radical in another protein (Lee 2005).   
3.1.7 Microstructure 
Micrographs of the treated WPI solution was shown in Figures 19 and 
20. In Figure 19, treated sample (A) has disorder and non-regular pattern 
structure. It seems protein structure was fragmented by gamma radiation and 
produced some voids. In contrast, untreated sample (B) had clean bands. In 
Figure 20, treated protein bands were smeared.  
Gamma radiation has two diametrically opposite effects on whey 
proteins aggregation and fragmentation. However, by high dosage of gamma 
radiation treatment, conformation of protein is generally aggregated to form 
high molecular weight.  
 
3.2 FUTURE WORK 
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Future work for this project would work on optimal dosage of gamma 
radiation to sterilize the model system and inhibit the growth of 
microorganisms for at least six months. This dosage should also have the 
minimal effects on protein-based functional and structural properties of whey 
protein.  
Next attempts may be in the range from 30% protein to 45% protein. 
BioGlue has 45% BSA as a polymer.  
Toxicological evaluations should also be included for the development 
of protein/glutaraldehyde tissue adhesives. Glutaraldehyde has been 
mentioned previously for its known toxicity. The percentage of glutaraldehyde 
did not only affect bonding strength, but also is a significant factor for 
toxicological testing. Animal experiments may be needed before the product 
enters human trial phases.  
After sterilizing WPI solutions by gamma radiation, gelation may be a 
factor that affected shelf life. To extend shelf life of this development, 
preventing from gelation is essential. Other than the dosage of gamma 
radiation, gelation inhibitor or an appropriate procedure may be an alternative 
to slow down gelling for future work.     
 
3.3 CONCLUSIONS 
Gamma radiation may cause protein-protein interactions resulting in 
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increase in viscosity, and bonding strength, decreasing pH 4.6 soluble N. 
Results indicated that gamma radiation may be suitable for sterilizing the 































































































































































































































































Figure 14. Effects of Gamma Radiation on the First Month Bonding 










































































Figure 15. Effects of Gamma Radiation on the Third Month Bonding 





































































Figure 16. Effects of Gamma Radiation on the Fifth Month Bonding 

































































Figure 17. Comparison of commercial tissue adhesive with 36% protein 









































Figure 18. SDS-PAGE Photographs of Whey Protein Profile before and 











Figure 19. Comparison of SEM Images of WPI Solutions (30% protein) 
before and after Gamma Radiation Treatment. A: WPI Solution 






A:                           B: 
  
 
C:                          D: 
  
Figure 20. SEM Images of WPI Solutions (30% protein) Treated by 0 
KGy (A), 10 KGy (B), 12.5 KGy (C), and 20 KGy (D) Gamma Radiation 
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